e-learning
resources
Virtual 2020
Pre-Congress Content
Translational therapeutic advances
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation
I. Piscaer (Maastricht, Netherlands), L. Kistemaker (Groningen, Netherlands), R. Gosens (Groningen, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), H. Frijlink (Groningen, Netherlands), R. Janssen (Nijmegen, Netherlands)
Source:
Virtual Congress 2020 – Translational therapeutic advances
Session:
Translational therapeutic advances
Session type:
E-poster session
Number:
3344
Disease area:
Airway diseases, Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Piscaer (Maastricht, Netherlands), L. Kistemaker (Groningen, Netherlands), R. Gosens (Groningen, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), H. Frijlink (Groningen, Netherlands), R. Janssen (Nijmegen, Netherlands). Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation. 3344
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema
Source: International Congress 2018 – Intercellular communication in tissue remodelling
Year: 2018
Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Antagonizing COVID19-induced GPR4 alleviates lung and kidney injury
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Late Breaking Abstract - Blockade of ß2-adrenoceptor augments anaphylaxis-induced increase in pulmonary vascular permeability in anesthetized mice
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Late Breaking Abstract - Aging impairs alveolar epithelial type II cell function in acute lung injury
Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Year: 2019
Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept